The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutanea tarda

Cutis

Volumn 78, Issue 6, 2006, Pages 397-400

  Chan, Owen T M ^a   Tsai, Naoky ^a   Wong, Ramona L ^a   Izumi, Allan K ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b Queen's Physicians Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFALEXIN; UROPORPHYRIN;

ARTICLE; CHRONIC KIDNEY FAILURE; HEPATITIS C; HUMAN; IRON OVERLOAD; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA;

ANTI-BACTERIAL AGENTS; CEPHALEXIN; HEPATITIS C, CHRONIC; HUMANS; IRON OVERLOAD; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PHLEBOTOMY; PORPHYRIA CUTANEA TARDA; UROPORPHYRINS;

EID: 33846151354     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bickers DR, Pathak MA, Lim HW. The porphyrias. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill; 1999:1766-1803.
2. Fitzpatrick TB, Johnson RA, Wolff K, et al. Color Atlas & Synopsis of Clinical Dermatology: Common and Serious Diseases. New York, NY: McGrawHill; 2001.
3. Elder GH. Porphyria cutanea tarda. Semin Liver Dis. 1998;18:67-75.
4. Bonkovsky HL, Lambrecht RW. Hemochromotosis, iron overload, and porphyria cutanea tarda. In: Barton JC, Edwards CQ, eds. Hemochromatosis: Genetics, Pathophysiology, Diagnosis and Treatment. Cambridge, United Kingdom: Cambridge University Press; 1999:453-467.
5. Hawk JLM, Morris PG. Abnormal responses to ultraviolet radiation: idiopathic. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill; 1999:1573-1589.
6. Kim JJ, Lim HW. Hexachlorobenzene and porphyria cutanea tarda. Arch Dermatol. 1999;135:459-460.
7. Poh-Fitzpatrick MB, Bellet N, DeLeo VA, et al. Porphyria cutanea tardia in two patients treated with hemodialysis for chronic renal failure. N Engl J Med. 1978;299:292-294.
8. Fargion S, Piperno A, Cappellini MD, et al. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology. 1992;16:1322-1326.
9. Lundvall O, Weinfeld A. Studies of the clinical and metabolic effects of phlebotomy treatment in porphyria cutanea tarda. Acta Med Scand. 1968;184:191-199.
10. Lambrecht RW, Bonkovsky HL. Hemochromatosis and porphyria. Semin Gastrointest Dis. 2002;13:109-119.
11. De Matteis F. Role of iron in the hydrogen peroxide-dependent oxidation of hexahydroporphyrins (porphyrinogens): a possible mechanism for the exacerbation by iron of hepatic uroporphyria. Mol Pharmocol. 1988;33:463-469.
12. Bonkowsky HL, Healey JF, Sinclair PR, et al. Iron and the liver: acute effects of iron-loading on hepatic heme synthesis of rats, role of decreased activity of 5-aminolevulinate dehydrase. J Clin Invest. 1983;71:1175-1182.
13. Cable E, Greene Y, Healey J, et al. Mechanism of synergistic induction of hepatic heme oxygenase by glutethimide and iron: studies in cultured chick embryo liver cells. Biochem Biophys Res Commun. 1990;168:176-181.
14. Lacour JP, Bodokh I, Castanet J, et al. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol. 1993;128:121-123.
15. Navas S, Bosch O, Castillo I, et al. Porphyria cutanea tarda and hepatitis C and B viruses infection: a retrospective study. Hepatology. 1995;21:279-284.
16. Cribier B, Rey D, Uhl G, et al. Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus, a study of 177 patients. Arch Dermatol. 1996;132:1448-1452.
17. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, et al. Measurements of iron status in patients with chronic hepatitis. Gastroenterology. 1992;102:2108-2113.
18. Riggio O, Montagnese F, Fiore P, et al. Iron overload in patients with chronic viral hepatitis: how common is it? Am J Gastroenterol. 1997;92:1298-1301.
19. Barbara G, Di Lorenzo G, Ribersani M, et al. Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol. 1999;30:774-782.
20. Jessner W, Der-Petrossian M, Christiansen L, et al. Porphyria cutanea tarda during interferon/ribavirin therapy for chronic hepatitis C. Hepatology. 2002;36:1301-1302.
21. Okano J, Horie Y, Kawasaki H, et al. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C. Hepatogastroenterology. 1997;44:525-528.
22. Takikawa H, Yamazaki R, Shoji S, et al. Normalization of urinary porphyrin level and disappearance of skin lesions after successful interferon therapy in a case of chronic hepatitis C complicated with porphyria cutanea tarda. J Hepatol. 1995;22:249-250.
23. Sarkell B, Patterson JW. Treatment of porphyria cutanea tarda of end-stage renal disease with erythropoietin. J Am Acad Dermatol. 1993;29:499-500.
24. Yaqoob M, Smyth J, Ahmad R, et al. Haemodialysis-related porphyria cutanea tarda and treatment by recombinant human erythropoietin. Nephron. 1992;60:428-431.
25. Anderson KE, Goeger DE, Carson RW, et al. Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis [erratum in N Engl J Med. 1990;332:1616]. N Engl J Med. 1990;322:315-317.
26. Lichtenstein JR, Babb EJ, Felsher BF. Porphyria cutanea tarda (PCT) in a patient with chronic renal failure on haemodialysis. Br J Dermatol. 1981;104:575-578.
27. Day RS, Eales L. Porphyrins in chronic renal failure, Nephron. 1980;26:90-95.
28. Kappas A, Sassa S, Galbraith RA, et al. The porphyrias. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease. New York, NY: McGraw-Hill; 1995:2103-2160.
29. Lundvall O. Phlebotomy treatment of porphyria cutanea tarda. Acta Dem Venereal Suppl (Stockh). 1982;100:107-118.
30. Adjarov D, Naydenova E, Ivanov E, et al. Choice of therapy in porphyria cutanea tarda. Clin Exp Dermatol. 1996;21:461-462.
31. Shieh S, Cohen JL, Lim HW. Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review. J Am Acad Dermatol. 2000;42:645-652.
32. Poux JM, Demontis R, Cadranel JF, et al. Porphyria cutanea tarda in a dialyzed patient with hepatitis C virus infection: dramatic efficacy of small repeated phlebotomies. Am J Med. 1997;103:163-164.